[HTML][HTML] Hepatotoxicity of small molecule protein kinase inhibitors for cancer
M Viganò, M La Milia, MV Grassini, N Pugliese… - Cancers, 2023 - mdpi.com
Simple Summary This review reports the risk and management of the hepatotoxicity of all the
approved protein kinase inhibitors (PKIs) for cancer. Hepatotoxicity is one of the major safety …
approved protein kinase inhibitors (PKIs) for cancer. Hepatotoxicity is one of the major safety …
[HTML][HTML] Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
M Viganò, M La Milia, MV Grassini, N Pugliese… - mdpi.com
Background: Approximately 10% of pediatric malignancies are secondary to germline
alterations in cancer-predisposing genes. Checkpoint kinase 2 (CHEK2) germline loss-of …
alterations in cancer-predisposing genes. Checkpoint kinase 2 (CHEK2) germline loss-of …
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
M Viganò, M La Milia, MV Grassini, N Pugliese… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Small molecule protein kinase inhibitors (PKIs) have become an effective strategy for cancer
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer.
M Viganò, M La Milia, MV Grassini, N Pugliese… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: This review reports the risk and management of the
hepatotoxicity of all the approved protein kinase inhibitors (PKIs) for cancer. Hepatotoxicity is …
hepatotoxicity of all the approved protein kinase inhibitors (PKIs) for cancer. Hepatotoxicity is …
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
M Viganò, M La Milia, MV Grassini, N Pugliese… - …, 2023 - search.proquest.com
Small molecule protein kinase inhibitors (PKIs) have become an effective strategy for cancer
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
M Vigano, M La Milia, M Grassini, N Pugliese… - CANCERS, 2023 - boa.unimib.it
Small molecule protein kinase inhibitors (PKIs) have become an effective strategy for cancer
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
[HTML][HTML] Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
M Viganò, M La Milia, MV Grassini, N Pugliese… - Cancers, 2023 - ncbi.nlm.nih.gov
Small molecule protein kinase inhibitors (PKIs) have become an effective strategy for cancer
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
M Viganò, M La Milia, M Grassini, N Pugliese… - Cancers, 2023 - europepmc.org
Small molecule protein kinase inhibitors (PKIs) have become an effective strategy for cancer
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
[PDF][PDF] Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer. Cancers 2023, 15, 1766
M Viganò, M La Milia, MV Grassini, N Pugliese… - 2023 - boa.unimib.it
Small molecule protein kinase inhibitors (PKIs) have become an effective strategy for cancer
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer.
M Viganò, M La Milia, MV Grassini, N Pugliese… - Cancers, 2023 - europepmc.org
Small molecule protein kinase inhibitors (PKIs) have become an effective strategy for cancer
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …
patients. However, hepatotoxicity is a major safety concern of these drugs, since the majority …